Morgan Stanley
JBIO icon

Morgan Stanley’s Jade Biosciences JBIO Stock Holding History

Morgan Stanley’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.77M Buy
124,513
+73,918
+146% +$1.54M ﹤0.01% 4656
2026
Q1 		$711K Sell
50,595
-29,172
-37% -$422K ﹤0.01% 5304
2025
Q4 		$1.23M Buy
79,767
+25,526
+47% +$299K ﹤0.01% 5076
2025
Q3 		$468K Buy
54,241
+4,468
+9% +$36.5K ﹤0.01% 5523
2025
Q2 		$497K Buy
49,773
+29,789
+149% +$1.01M ﹤0.01% 5459
2025
Q1 		$1.76M Sell
19,984
-2,489
-11% -$219K ﹤0.01% 4687
2024
Q4 		$2.08M Buy
22,473
+12,931
+136% +$1.11M ﹤0.01% 4671
2024
Q3 		$698K Buy
9,542
+8,063
+545% +$520K ﹤0.01% 5238
2024
Q2 		$85.9K Buy
1,479
+728
+97% +$483K ﹤0.01% 6013
2024
Q1 		$777K Sell
751
-250
-25% -$191K ﹤0.01% 5105
2023
Q4 		$793K Buy
1,001
+457
+84% +$233K ﹤0.01% 5058
2023
Q3 		$259K Sell
544
-400
-42% -$217K ﹤0.01% 5466
2023
Q2 		$566K Sell
944
-341
-27% -$218K ﹤0.01% 5144
2023
Q1 		$907K Buy
1,285
+1,222
+1,940% +$1.01M ﹤0.01% 4913
2022
Q4 		$64.2K Sell
63
-73
-54% -$53K ﹤0.01% 6181
2022
Q3 		$78K Sell
136
-91
-40% -$60.7K ﹤0.01% 6204
2022
Q2 		$124K Buy
227
+11
+5% +$5.25K ﹤0.01% 6158
2022
Q1 		$139K Sell
216
-11
-5% -$4.27K ﹤0.01% 6117
2021
Q4 		$94K Buy
227
+149
+191% +$75.4K ﹤0.01% 6483
2021
Q3 		$57K Buy
+78
New +$43.7K ﹤0.01% 6661

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Bellevue Group
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Paradigm Biocapital Advisors
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley's JBIO Position: Q2 2026 in Review

Morgan Stanley increased its Jade Biosciences (JBIO) stake by 146% in Q2 2026, buying an estimated $1.54M and bringing the position to 124,513 shares worth $2.77M. The position accounts for ﹤0.01% of the portfolio, ranked #4656.

Morgan Stanley first reported a position in JBIO in Q3 2021 and has held it in 20 quarters since. 153 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Morgan Stanley held 124,513 shares of Jade Biosciences worth $2.77M as of Q2 2026.
  • Morgan Stanley bought 73,918 Jade Biosciences shares in Q2 2026, an estimated $1.54M.
  • Jade Biosciences made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #4656 holding.
  • Morgan Stanley first reported a position in Jade Biosciences in Q3 2021 and has held it in 20 quarters since.
  • 153 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.